NORM is here to partner with you to chart a course of continued success and sustainability. Change is never easy, but in the rheumatology world, it is a constant. Preparing our physicians and staff to anticipate changes and effectively navigate them is part of our job as leaders within our practices.
According to the results of 2 separate clinical trials presented at the 2018 Genitourinary Cancers Symposium, apalutamide and enzalutamide reduced the risk for metastasis and prolonged metastasis-free survival in patients with nonmetastatic castrate-resistant prostate cancer.
Our news blog is comprised of several categories, including Healthy Lifestyle, Holidays, Industry News, Minute with the Board, NORM Events, NORM News, Resources, Social Media, and Tips and Tricks.
Happy holidays and warmest wishes to you and your staff from the National Organization of Rheumatology Managers (NORM)!
In a recent interview, Ms Zlatkus shared comments about her aspirations as President of NORM and Editor-in-Chief of RPM.
Scott Gottlieb was recently confirmed as FDA Commissioner. It is believed that he would be able to swiftly execute changes that could help to accelerate drug approvals and lower drug prices to meet Trump’s goals.
Read Now
Stay up to date with urology news & updates by subscribing to receive the free UPM print publications or e‑Newsletters.